ZADH2 Inhibitors
Chemical inhibitors of ZADH2 can affect the enzyme's function through various modes of action. 4-Methylpyrazole and Fomepizole are known to inhibit enzymes similar to ZADH2 that are involved in oxidoreductase activities. By targeting these enzymes, the availability of essential cofactors such as NADPH required for ZADH2's reductase activity can be reduced, leading to an inhibition of ZADH2 function. Disulfiram, which is known to bind to catalytic and structural zinc ions in certain enzymes, can inhibit ZADH2 by interfering with its zinc-binding sites, as ZADH2 is a zinc-dependent enzyme. This interaction can disrupt the proper conformation and function of ZADH2 necessary for its enzyme activity.
Furthermore, aldose reductase inhibitors such as Tolrestat and Epalrestat can decrease the intracellular levels of NADPH, a cofactor essential for the enzymatic activity of ZADH2. By reducing the availability of NADPH, these inhibitors can indirectly lead to functional inhibition of ZADH2. Other chemicals such as Sorafenib and Tipranavir, although they target different proteins like RAF kinases and HIV-1 protease respectively, can influence cellular signaling pathways and the proteostasis network. These changes can alter the redox balance within cells, subsequently inhibiting redox-sensitive enzymes such as ZADH2. Omeprazole's inhibition of cytochrome P450 enzymes and Methimazole's inhibition of thyroid peroxidase can lead to altered redox states in cells, which can also negatively impact the enzymatic activity of ZADH2. Acarbose influences the NADPH/NADP+ ratio by altering carbohydrate metabolism, which in turn can inhibit ZADH2, while Allopurinol's action on xanthine oxidase can cause changes in the cellular redox state, potentially inhibiting ZADH2 activity as a result. Each chemical, through its unique interaction with cellular components, can lead to a decrease in ZADH2 activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Fomepizole | 7554-65-6 | sc-252838 | 1 g | $75.00 | 1 | |
This chemical inhibits alcohol dehydrogenase, an enzyme that shares functional similarities with ZADH2 in terms of oxidoreductase activity. By inhibiting alcohol dehydrogenase, 4-Methylpyrazole can reduce the availability of cofactors necessary for ZADH2 function, thereby inhibiting ZADH2. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram inhibits acetaldehyde dehydrogenase and can also inhibit other aldehyde dehydrogenases by binding to the catalytic and structural zinc ions. As ZADH2 is a zinc-containing enzyme, disulfiram can inhibit its activity by interfering with its zinc-binding sites. | ||||||
Epalrestat | 82159-09-9 | sc-218319 | 10 mg | $200.00 | 2 | |
Epalrestat works similarly to Tolrestat by inhibiting aldose reductase. This inhibition can decrease the intracellular levels of NADPH. As ZADH2 requires NADPH for its reductase activity, the reduction in NADPH levels due to Epalrestat can result in the functional inhibition of ZADH2. | ||||||
Daclatasvir | 1009119-64-5 | sc-500663 | 100 mg | $330.00 | ||
Daclatasvir inhibits the NS5A protein of the hepatitis C virus, which is involved in viral replication. This protein interacts with host cell proteins that are part of redox processes. By inhibiting proteins involved in these processes, Daclatasvir could indirectly inhibit the redox activity of ZADH2. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Sorafenib is a kinase inhibitor that targets RAF kinases, among others. By inhibiting RAF kinases, Sorafenib can influence cellular signaling pathways involved in metabolism and redox balance. This can lead to a functional inhibition of ZADH2, which participates in cellular redox reactions. | ||||||
Tipranavir | 174484-41-4 | sc-220260 | 1 mg | $305.00 | 2 | |
Tipranavir is a protease inhibitor used to inhibit HIV-1 protease. Protease inhibitors can affect the proteostasis network within cells, potentially leading to altered redox states. This alteration can inhibit the function of redox-sensitive enzymes like ZADH2. | ||||||
Omeprazole | 73590-58-6 | sc-202265 | 50 mg | $67.00 | 4 | |
Omeprazole inhibits the H+/K+ ATPase in gastric parietal cells. It also has been shown to inhibit some cytochrome P450 enzymes. As ZADH2 has a role in redox reactions, the inhibition of cytochrome P450 enzymes could lead to altered redox states in cells, which might inhibit ZADH2 activity. | ||||||
Methimazole | 60-56-0 | sc-205747 sc-205747A | 10 g 25 g | $70.00 $112.00 | 4 | |
Methimazole inhibits thyroid peroxidase, which could lead to reduced hydrogen peroxide levels in thyroid cells. Lowered hydrogen peroxide levels can influence global cellular redox states. Since ZADH2 is sensitive to the redox status, methimazole could result in functional inhibition of ZADH2. | ||||||
Acarbose | 56180-94-0 | sc-203492 sc-203492A | 1 g 5 g | $226.00 $605.00 | 1 | |
Acarbose inhibits alpha-glucosidases, enzymes involved in carbohydrate digestion. By altering carbohydrate metabolism, Acarbose could influence the NADPH/NADP+ ratio in cells. Since ZADH2 relies on NADPH for its reductase activity, a change in this ratio could lead to functional inhibition of ZADH2. | ||||||
Allopurinol | 315-30-0 | sc-207272 | 25 g | $131.00 | ||
Allopurinol is an inhibitor of xanthine oxidase, an enzyme involved in purine metabolism. The inhibition of xanthine oxidase can lead to alterations in the cellular redox state, which could inhibit the function of other redox-active enzymes such as ZADH2. | ||||||